Neuroprotection and Traumatic Brain Injury: The Search Continues
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
During the last decade, experimental studies of traumatic brain injury (TBI) have provided important new insights into the pathophysiological mechanisms leading to posttraumatic tissue damage and associated neurological dysfunction. The concept of delayed or secondary tissue injury has strong experimental support and a cascade of secondary injury factors has been delineated. 1,2 These observations have led to the application of targeted pharmacotherapies, whose aim is to block specific pathobiological pathways. 2,3 Such research has been aided by the development of rodent models of head injury that simulate critical components of clinical neurotrauma, as well as by the development of novel neuroprotective agents. 3,4 These experimental studies have identified mechanisms of delayed tissue damage and have demonstrated the effectiveness of a number of pharmacological treatment strategies, 1-4 However, despite this enormous experimental promise, the clinical studies to date have been disappointing, 5,6 Here we explore the conceptual and methodological issues that have contributed to this discrepancy between preclinical and clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508 · cited 1×
“Some of these approaches, such as the use of N-methyl-Daspartate receptor antagonists, have particularly strong experimental support.(8,11) More recently, it has also been shown that modulation of apoptotic cell death by inhibiting caspases also improves outcome after TBI.”
MethodSelf-citation
Cited by
Gladstone, D. J., Black, S. E., & Hakim, A. M. (2002) · Stroke · doi:10.1161/01.str.0000025518.34157.51 · Cited by 635
Cernak, I. (2005) · NeuroRX · doi:10.1602/neurorx.2.3.410 · Cited by 462
Noninvasive brain stimulation to modulate neuroplasticity in traumatic brain injury
Villamar, M. F., Santos Portilla, A., Fregni, F., & Zafonte, R. (2012) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/j.1525-1403.2012.00474.x · Cited by 119
Hughes, R. H., Silva, V. A., Ahmed, I., Shreiber, D. I., & Morrison, B. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.020 · Cited by 46
“Often patients who experience a TBI or stroke are unable to receive immediate treatment and may not reach medical assistance for hours after injury.”
BackgroundInfluential(2002) · doi:10.14670/hh-17.1137
Metadata
- Authors
- Faden, A. I.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-10-01
- Volume
- 58
- Issue
- 10
- Pages
- 1553
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2057079435
- Cited by
- 57
- References
- 1
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotection and Traumatic Brain Injury: The Search Continues. https://app.cochat.ai/papers/10.1001/archneur.58.10.1553
- The paper
- Faden, A. I. (2001). Neuroprotection and Traumatic Brain Injury: The Search Continues. Archives of Neurology. https://doi.org/10.1001/archneur.58.10.1553
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.